Pharmaceuticals News and Research

RSS

Autistic children with co-occurring ADHD have greater adaptive behavior impairments

A pair of new studies has provided new insight into the challenges faced by children on the autism spectrum who exhibit symptoms of attention deficit/hyperactivity disorder.

19 Feb 2019

The high cost of sex: Insurers often don’t pay for drugs to treat problems

For some older people, the joy of sex may be tempered by financial concerns: Can they afford the medications they need to improve their experience between the sheets?

19 Feb 2019

Using light-based method for production of pharmaceutical molecules

Photoelectrochemical cells are widely studied for the conversion of solar energy into chemical fuels. They use photocathodes and photoanodes to "split" water into hydrogen and oxygen respectively.

18 Feb 2019

High-protein and low-calorie diet helps older adults lose weight safely, shows study

A high-protein, low-calorie diet helps older adults with obesity lose more weight, maintain more muscle mass, improve bone quality and lose "bad" fat, according to results from a new randomized controlled trial led by Wake Forest University researcher Kristen Beavers.

15 Feb 2019

Keynote speakers announced for CBD Expo MIDWEST

CBD Expo Tour 2019, produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

New method analyzes how single biological cells react to stressful situations

Human beings are not the only ones who suffer from stress - even microorganisms can be affected. Now, researchers from Chalmers University of Technology, Sweden, have devised a new method to study how single biological cells react to stressful situations.

13 Feb 2019

False lead: Senator’s offer to help patient import cheap insulin goes nowhere

It sounded like an answer to prayers for millions with diabetes struggling to pay soaring prices for insulin.

11 Feb 2019

Researchers report promising advance in the search for new class of antidepressants

In experiments with mice, researchers at Johns Hopkins Medicine report a promising advance in the search for a new class of drugs to treat major depression.

8 Feb 2019

What ‘dope sick’ really feels like

Detoxing off heroin or opioids without medication is sheer hell. I should know. For many users, full-blown withdrawal is often foreshadowed by a yawn, or perhaps a runny nose, a sore back, sensitive skin or a restless leg. For me, the telltale sign that the heroin was wearing off was a slight tingling sensation when I urinated.

8 Feb 2019

Drug that reverses blood thinning effects stops acute life-threatening bleeding

A drug that reverses the blood thinning effects of factor Xa inhibitors effectively stopped acute life-threatening bleeding in patients taking a factor Xa inhibitor blood thinner drug, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

Podcast: KHN’s ‘What the Health?’ A ‘healthy’ state of the union

Health policy played a surprisingly robust role in President Donald Trump's 2019 State of the Union address.

7 Feb 2019

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

7 Feb 2019

LABVOLUTION: A digitized lab environment to be showcased at smartLAB 2019

In 2019, networking and interaction between people, machines and systems will be the primary focus of the smartLAB showcase. For the third time in succession, this project will pose the vision of leading-edge networked laboratories that incorporate new technology, thereby extending their range of capabilities.

From LABVOLUTION 7 Feb 2019

New physical effect could lead to advancements in personalized pharmaceuticals

A new physical effect has been demonstrated at the University of Bath after 40 years of pursuit by physicists around the world, which could lead to advancements in chemical manufacturing efficiency, miniaturization and quality control in personalized pharmaceuticals.

7 Feb 2019

New acute porphyria treatment shows promising results in clinical study

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the only effective treatment available for the most seriously afflicted patients.

7 Feb 2019

Largest description of ST3GAL5 deficiency combined using data from 104 individuals

Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.

6 Feb 2019

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

It was not the centerpiece, but health was a persistent theme in President Donald Trump's State of the Union address at the Capitol on Tuesday night.

6 Feb 2019

Study: Promising new treatment for children with ADHD shows improvement in efficacy

A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder, showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study.

4 Feb 2019

Lawsuit details how the Sackler family allegedly built an Oxycontin fortune

The first nine months of 2013 started off as a banner year for the Sackler family, owners of the pharmaceutical company that produces OxyContin, the addictive opioid pain medication. Purdue Pharma paid the family $400 million from its profits during that time, claims a lawsuit filed by the Massachusetts attorney general.

4 Feb 2019